GSK's Trading Volume Surges 46.41% to Rank 250th in Market

On April 29, 2025, GSK's trading volume reached 3.21 billion, marking a 46.41% increase from the previous day. This surge placed GSK at the 250th position in terms of trading volume for the day. GSK's stock price rose by 2.39%, marking the second consecutive day of gains, with a total increase of 4.11% over the past two days.

GSK is expected to report its first-quarter 2025 earnings on April 30, before the market opens. Analysts anticipate that the company will announce earnings of $1.06 per share and revenue of $7.52 billion for the quarter. GSK has set its FY 2025 guidance at 2.090-2.090 per share.

Barclays has indicated that GSK's first-quarter 2025 results may be impacted by the performance of its vaccines division. The consensus EPS forecast for the fiscal quarter ending March 2025 has remained stable at $1.08 over the past week, with an increase from $1.06 over the past month.

Zacks Research has revised its earnings estimate for GSK, now anticipating earnings per share of $1.07 for the quarter, down from their previous estimate. This adjustment reflects the ongoing challenges faced by the company, particularly in its vaccines segment.